We have a suspicion that you are an automated web bot software, not a real user. To keep our site fast for other users, we have slowed down this page. The slowdown will gradually disappear. If you think this is a mistake, please contact us at genome-www@soe.ucsc.edu. Also note that all data for hgGeneGraph can be obtained through our public MySQL server and all our software source code is available and can be installed locally onto your own computer. If you are unsure how to use these resources, do not hesitate to contact us.
UCSC Genome Browser Gene Interaction Graph
Gene interactions and pathways from curated databases and text-mining

◀ Back to PRKAA1

CALM3 — PRKAA1

Text-mined interactions from Literome

Thornton et al., J Biol Chem 2008 : Rather than restoring mRNA levels to baseline, pharmacological inhibition of Ca ( 2+ ) /calmodulin dependent protein kinase kinase beta or AMPK greatly increases Agouti related peptide and melanin concentrating hormone mRNA expression
Murgia et al., J Physiol 2009 : The Ca ( 2+ ) -calmodulin dependent kinase II ( CaMKII ), calcineurin and AMPK pathways have been implicated in GLUT4 gene regulation based on pharmacological evidence
Chikahisa et al., Neuropharmacology 2009 (Sleep Deprivation) : Sleep deprivation ( SD ) for 6 h increased p-AMPK protein in the hypothalamus and also increased the mRNA level of Ca ( 2+ ) /calmodulin (CaM) dependent protein kinase kinase beta ( CaMKK2 ), an activator of AMPK , and carnitine palmitoyltransferase 1 (CPT1), a downstream signaling factor of AMPK
Gusarova et al., Mol Cell Biol 2011 (Anoxia) : This increase in intracellular Ca ( 2+ ) induces Ca ( 2+ ) /calmodulin dependent kinase kinase ß ( CaMKKß ) -mediated AMPK activation and Na, K-ATPase downregulation
Douillard et al., Clin Exp Pharmacol Physiol 2012 (Hypertrophy) : In addition to other pathways, the Akt/mammalian target of rapamycin (mTOR) pathway, controlling protein synthesis, and the calcium/calmodulin dependent protein kinase 2 ( CamK2 ) and AMP activated protein kinase (AMPK) pathways, recently identified as calpain substrates, could be relevant in ß ( 2 ) -adrenoceptor agonist induced skeletal muscle remodelling
Brock et al., J Biol Chem 2012 (Carcinoma, Non-Small-Cell Lung...) : Our data further indicate that MIF and d-DT, acting through their shared cell surface receptor, CD74, antagonize NSCLC AMPK activation by maintaining glucose uptake, ATP production, and redox balance, resulting in reduced Ca ( 2+ ) /calmodulin dependent kinase kinase ß-dependent AMPK activation
Quan et al., Biochem Pharmacol 2013 (Fatty Liver) : Ca(+2)-calmodulin dependent protein kinase kinase ( CAMKK ) and AMP activated protein kinase (AMPK) were both activated by BA treatment
Hawley et al., J Biol Chem 1995 : The availability of alternative substrates for AMPKK and CaMKIK allowed the unequivocal demonstration that AMP and Ca2+/calmodulin promote the activation of AMPK and Ca2+/calmodulin promote the activation of AMPK and CaMKI, respectively, via three independent mechanisms : 1 ) direct activation of AMPK and CaMKI, 2 ) activation of AMPKK and CaMKIK, and 3 ) by binding to AMPK and CaMKI, inducing exposure of their phosphorylation sites